^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
SG1906
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Sumgen Biotech
Drug class:
CD47 inhibitor, CLDN18.2 inhibitor
Related drugs:
Phase 1
Hangzhou Sumgen Biotech Co., Ltd.
Recruiting
Last update posted :
11/21/2023
Initiation :
05/30/2023
Primary completion :
02/28/2025
Completion :
08/30/2025
CLDN18
|
CLDN18.2 positive
|
SG1906
Share
